Your browser doesn't seem to be up to date

We see that you are currently using an old version of Internet Explorer. We recommend that you update your browser.

We are active owners who value stability, commitment and entrepreneurship

Our investments
↳ Atleva — Specialist care
↳ Atvexa — Preschool and School
↳ Atviva — Health and Social Care
↳ My Clinical Outcomes — Healthcare
↳ CTR— Clinical tests
↳ CTR — Clinical trials
↳ Other investments

Active investments in a limited number of companies

We have a limited number of investments, where we contribute with our knowledge, experience and capital. Our philosophy is simple; we choose industries we understand and businesses that are stable and where we see an opportunity to generate growth.

Our Investments →

Atnotera is an independent investment company working network based. We invest in companies that support human development and well-being

The opportunity to contribute towards developing these businesses and co-operating with committed people is our main motivator. It is key for us that all stakeholders feel that our collaboration is rewarding and that both people and businesses develop. These are key success criteria to us and enabling a good investment.

About Us →

News

↳ Here we publish news related to Atnotera's investments
2024-10-09

Atleva Specialist care recruits a CEO and strengthens the board

The board of Atleva Specialistvård AB has appointed Karl Johansson Bäckgren as the new CEO. During the autumn, there will be another positive change when the board is strengthened with former regional director Ann-Sofi Lodin and Carsten Browall, board member of Bure Equity, among others.

Read the full article →
2024-08-26

New CEO for AtlevaSpecialistvård AB

The Board of Directors of Atleva Specialistvård AB has appointed Karl Johansson Bäckgren as new CEO.

Read the full article →
2024-07-03

Center for Translational Research acquires Zelmic AB

CTR acquires Lund-based topical pharmaceuticals company

Read the full article →